The Executive Committee decided to approve the project for the phase-out of CFC consumption in the manufacturing of metered-dose inhalers in Argentina, at the amount of US$2,806,874 plus agency support costs of US $210,516 to the World Bank, on the understanding that:
- Laboratorio Pablo Cassará will cease consumption of CFCs for non-essential uses and convert to a non-ODS technology at its own cost if the selection of the isobutane technology proposed by the enterprise is not approved by the local health authorities; and
- The Government of Argentina will have flexibility in using the funding available for eligible activities it deems appropriate to achieve the complete phase-out of CFCs in the MDI sector and in accordance with relevant decisions and guidelines of the Fund.